Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Drug Discovery 2025, ELRIG – 04.07.2025
DDL 2025
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
HCMed

Three ‘Ps’ for Implementing an Effective eCOA Strategy: People, Processes, and Plan

Clinical scientists have proven that the collection of clinical outcome
assessment data with an electronic device improves patient
compliance and delivers higher quality and more reliable data.
The value of electronic clinical outcome assessment data for clinical
trial claims, post-marketing safety studies and patient registries has
become increasingly recognised by various stakeholders, including
regulatory authorities and health economics outcomes research
experts. D. Eek, C. Hall, S. Hooper, F. Wald and M. Wurm at ERT.
https://international-pharma.com/wp-content/uploads/2016/07/Clinical-Res-1-Three-Ps.pdf

YPSOMED website ad
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025